Profile data is unavailable for this security.
About the company
Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Company’s lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight management and patients with type 2 diabetes, respectively. Its other pipeline product candidates include NPM-139, and OKV-119. It uses this platform technology to develop and commercialize drug implant candidates for the treatment of chronic disease and medication non-adherence. It operates through two segments: Biopharm Division and Neuromodulation Division. The Company’s implant technology, which it refers as NanoPortal, utilizes a space-efficient design that allows a miniaturized implant to provide many months of therapeutic delivery of potent molecules.
- Revenue in USD (TTM)0.00
- Net income in USD-24.20m
- Incorporated2003
- Employees44.00
- LocationVivani Medical Inc1350 S. LOOP ROADALAMEDA 94502United StatesUSA
- Phone+1 (818) 833-5000
- Fax+1 (818) 833-5067
- Websitehttp://www.secondsight.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kronos Bio Inc | 8.41m | -102.85m | 62.10m | 58.00 | -- | 0.5041 | -- | 7.38 | -1.75 | -1.75 | 0.1425 | 2.04 | 0.0396 | -- | -- | 135,661.30 | -48.41 | -35.47 | -53.26 | -37.14 | -- | -- | -1,222.83 | -7,975.76 | -- | -- | 0.00 | -- | -- | -- | 15.41 | -- | -8.78 | -- |
Rapt Therapeutics Inc | 0.00 | -120.43m | 62.48m | 122.00 | -- | 0.572 | -- | -- | -3.12 | -3.12 | 0.00 | 3.13 | 0.00 | -- | -- | 0.00 | -69.23 | -46.30 | -75.81 | -49.97 | -- | -- | -- | -3,522.72 | -- | -- | 0.00 | -- | -100.00 | -- | -39.31 | -- | -20.31 | -- |
RetinalGenix Technologies Inc | 0.00 | -4.04m | 62.51m | 0.00 | -- | -- | -- | -- | -0.2291 | -0.2291 | 0.00 | -0.101 | 0.00 | -- | -- | -- | -9,059.05 | -9,163.75 | -- | -- | -- | -- | -- | -- | -- | -1,050.46 | -- | -- | -- | -- | 46.58 | -- | -- | -- |
enVVeno Medical Corp | 0.00 | -20.60m | 63.32m | 31.00 | -- | 1.65 | -- | -- | -1.43 | -1.43 | 0.00 | 2.88 | 0.00 | -- | -- | 0.00 | -56.37 | -58.43 | -59.43 | -62.76 | -- | -- | -- | -260,799.30 | -- | -- | 0.00 | -- | -- | -- | 4.67 | -- | 21.58 | -- |
Champions Oncology Inc | 51.66m | -3.40m | 64.84m | 210.00 | -- | -- | -- | 1.26 | -0.2541 | -0.2541 | 3.78 | -0.0244 | 1.88 | -- | 5.75 | 245,976.20 | -12.39 | -10.00 | -44.43 | -23.00 | 44.27 | 46.58 | -6.58 | -6.04 | -- | -- | 333.00 | -- | -6.90 | 13.13 | -36.38 | -- | 0.0479 | -- |
Celularity Inc | 22.77m | -196.30m | 65.51m | 120.00 | -- | 1.41 | -- | 2.88 | -11.29 | -11.29 | 1.30 | 2.11 | 0.0836 | 2.90 | 2.39 | 189,758.30 | -72.04 | -19.19 | -94.47 | -20.99 | 29.66 | -- | -862.04 | -454.79 | 0.2086 | 1.37 | 0.4893 | -- | 26.68 | -- | -1,483.14 | -- | -- | -- |
Connect Biopharma Holdings Ltd (ADR) | 24.12m | -21.25m | 67.96m | 81.00 | -- | 0.6152 | -- | 2.82 | -0.3869 | -0.3869 | 0.436 | 2.00 | 0.1826 | -- | -- | 297,728.40 | -16.09 | -66.24 | -17.73 | -71.36 | -- | -- | -88.10 | -- | -- | -- | 0.0029 | -- | -- | -- | 49.61 | -- | 10.32 | -- |
Vivani Medical Inc | 0.00 | -24.20m | 67.96m | 44.00 | -- | 2.85 | -- | -- | -0.4643 | -0.4643 | 0.00 | 0.4316 | 0.00 | -- | -- | 0.00 | -44.89 | -56.58 | -50.97 | -67.66 | -- | -- | -- | -2,868.72 | -- | -- | 0.00 | -- | -- | -- | -84.69 | -- | 40.33 | -- |
Maia Biotechnology Inc | 0.00 | -28.08m | 69.09m | 13.00 | -- | 21.70 | -- | -- | -1.62 | -1.62 | 0.00 | 0.1332 | 0.00 | -- | -- | 0.00 | -251.96 | -- | -362.21 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -21.91 | -- | -- | -- |
Precision BioSciences Inc | 87.64m | 15.79m | 69.52m | 110.00 | -- | 0.9162 | 3.32 | 0.7932 | -0.1363 | 0.202 | 17.59 | 10.49 | 0.5044 | -- | 79.03 | 804,036.70 | 9.09 | -35.35 | 12.24 | -44.22 | -- | -- | 18.02 | -147.50 | -- | -- | 0.2314 | -- | 94.15 | 34.96 | 41.67 | -- | -32.01 | -- |
OS Therapies Inc | 0.00 | -6.55m | 69.77m | 4.00 | -- | -- | -- | -- | -0.3011 | -0.3011 | 0.00 | -1.32 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -0.9763 | -- | -- | -- | -- | -24.09 | -- | -- | -- |
Spero Therapeutics Inc | 118.46m | 17.46m | 71.89m | 46.00 | 4.20 | 0.8923 | 4.08 | 0.6068 | 0.3169 | 0.3169 | 2.21 | 1.49 | 0.9524 | -- | 4.11 | 2,575,196.00 | 14.03 | -35.52 | 18.79 | -41.75 | -- | -- | 14.74 | -124.40 | -- | -- | 0.00 | -- | 93.95 | 92.11 | 149.14 | -- | -- | -- |
MDxHealth SA | 80.74m | -40.80m | 72.04m | 300.00 | -- | -- | -- | 0.8922 | -1.54 | -1.54 | 3.06 | -0.3229 | 0.5906 | 9.39 | 7.49 | 269,136.70 | -29.85 | -51.62 | -43.63 | -64.72 | 62.64 | 50.88 | -50.54 | -117.64 | 0.8252 | -1.74 | 1.18 | -- | 89.43 | 19.84 | 2.14 | -- | 30.13 | -- |
Holder | Shares | % Held |
---|---|---|
Sabby Management LLCas of 30 Jun 2024 | 2.13m | 3.85% |
Tanager Wealth Management LLPas of 30 Jun 2024 | 1.30m | 2.36% |
The Vanguard Group, Inc.as of 30 Jun 2024 | 884.05k | 1.60% |
Commonwealth Equity Services LLCas of 30 Jun 2024 | 330.53k | 0.60% |
Geode Capital Management LLCas of 30 Jun 2024 | 327.88k | 0.59% |
Monetary Management Group, Inc.as of 30 Jun 2024 | 193.98k | 0.35% |
SSgA Funds Management, Inc.as of 30 Jun 2024 | 128.80k | 0.23% |
Evoke Wealth LLCas of 30 Jun 2024 | 99.87k | 0.18% |
BlackRock Fund Advisorsas of 30 Jun 2024 | 64.24k | 0.12% |
Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 2024 | 60.38k | 0.11% |